Stress and expression of cyclooxygenases ( cox1, cox2a, cox2b ) and intestinal eicosanoids, in Atlantic salmon, Salmo salar L
In the key Phase 3 ATTAIN-1 trial published in the New England Journal of Medicine in 2025, once-daily orforglipron 36 mg produced mean body weight reductions of 11.2% at 72 weeks in adults with obesity, with nearly 55% of participants achieving at least 10% weight loss and 36% achieving 15% or more
Lower Cholesterol Lowers cholesterol by improving lipid metabolism
Sarah Stalker, D-Louisville, asked about the current standard in dentistry regarding fluoride treatment
By understanding how glutathione affects your body and following expert guidelines, you can safely use it without compromising your hair health
Lowering your dose or pausing an increase is never a failure